Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Candriam S.C.A. Sells 1,831 Shares of Vertex Pharmaceuticals Incorporated $VRTX
04:48am, Monday, 09'th Feb 2026
Candriam S.C.A. lowered its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 1.0% during the third quarter, according to the company in its most recent filing with the Securiti
Jones Financial Companies Lllp Has $2.75 Million Holdings in Vertex Pharmaceuticals Incorporated $VRTX
03:32am, Monday, 09'th Feb 2026
Jones Financial Companies Lllp grew its stake in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 18.4% during the third quarter, according to its most recent Form 13F filing with the Securities
The Bond Market Is Flashing a Clear Warning About the Fed: 3 Stocks to Buy
02:55am, Sunday, 08'th Feb 2026
The yield curve has steepened following President Trump's nomination of Kevin Warch as the next Fed chair. This could translate to higher inflation and market volatility.
2 Top Healthcare Stocks to Buy in February
12:39pm, Saturday, 07'th Feb 2026
Intuitive Surgical's recent dip is a good buying opportunity, considering its prospects. Vertex Pharmaceuticals' shares could jump this year as it advances its clinical programs.
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Thursday, 05'th Feb 2026
Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by AGF Management Ltd.
04:40am, Thursday, 05'th Feb 2026
AGF Management Ltd. decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 54.2% during the undefined quarter, according to the company in its most recent 13F filing with the Sec
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Mission Wealth Management LP
04:40am, Thursday, 05'th Feb 2026
Mission Wealth Management LP cut its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 30.5% during the third quarter, according to the company in its most recent Form 13F fi
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Wednesday, 04'th Feb 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Is Trending Stock Vertex Pharmaceuticals Incorporated (VRTX) a Buy Now?
10:00am, Tuesday, 03'rd Feb 2026
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Thrivent Financial for Lutherans Sells 9,932 Shares of Vertex Pharmaceuticals Incorporated $VRTX
05:02am, Tuesday, 03'rd Feb 2026
Thrivent Financial for Lutherans reduced its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 11.3% in the third quarter, according to the company in its most recent 13F fil
Atlantic Union Bankshares Corp Purchases 5,741 Shares of Vertex Pharmaceuticals Incorporated $VRTX
05:02am, Tuesday, 03'rd Feb 2026
Atlantic Union Bankshares Corp raised its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 64.2% during the third quarter, according to the company in its most recent 13F fi
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by WCM Investment Management LLC
05:02am, Tuesday, 03'rd Feb 2026
WCM Investment Management LLC decreased its position in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 1.2% during the undefined quarter, according to the company in its most recent disclosure
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
10:08pm, Monday, 02'nd Feb 2026
SHANGHAI, Feb. 2, 2026 /PRNewswire/ -- WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license
Principal Financial Group Inc. Reduces Holdings in Vertex Pharmaceuticals Incorporated $VRTX
04:21am, Monday, 02'nd Feb 2026
Principal Financial Group Inc. lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 0.8% in the third quarter, according to its most recent filing with the Securitie
Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today
06:51pm, Friday, 30'th Jan 2026
Vertex Pharmaceuticals (VRTX) reached $470.1 at the closing of the latest trading day, reflecting a -1.17% change compared to its last close.
